Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-31,054
Closed -$120K 1815
2025
Q3
$120K Buy
+31,054
New +$155K ﹤0.01% 1811
2022
Q1
Sell
-22,241
Closed -$1.41M 1158
2021
Q4
$1.41M Buy
+22,241
New +$1.75M ﹤0.01% 1091
2021
Q1
Sell
-1,487
Closed -$93K 2208
2020
Q4
$93K Buy
+1,487
New +$110K ﹤0.01% 2226
2020
Q3
Sell
-3,907
Closed -$301K 2302
2020
Q2
$301K Buy
3,907
+226
+6% +$13.5K ﹤0.01% 2099
2020
Q1
$177K Sell
3,681
-12,234
-77% -$768K ﹤0.01% 1745
2019
Q4
$1.27M Buy
+15,915
New +$1.07M ﹤0.01% 1275

Other funds holding AGEN

Arrowstreet Capital's AGEN Position: Q4 2025 in Review

Arrowstreet Capital sold out of Agenus (AGEN) in Q4 2025, closing a stake of 31,054 shares — an estimated $120K sold.

Arrowstreet Capital first reported a position in AGEN in Q4 2019 and held it in 6 quarters. The position peaked at $1.41M in Q4 2021. 96 funds tracked by Wall St. Rank hold AGEN as of Q4 2025.

  • Arrowstreet Capital reported no remaining Agenus position as of Q4 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 31,054 Agenus shares in Q4 2025, an estimated $120K.
  • Arrowstreet Capital first reported a position in Agenus in Q4 2019 and held it in 6 quarters.
  • Arrowstreet Capital's Agenus position peaked at $1.41M in Q4 2021.
  • 96 funds tracked by Wall St. Rank held Agenus as of Q4 2025.

Based on Arrowstreet Capital's 13F filing for Q4 2025, filed 13 Feb 2026.